pattern 1
frequent 1
nontargeted 1
pharmacologic 1
thromboprophylaxis 1
hospitalized 1
patients 2
cancer 1
academic 1
medical 1
centers 1
prospective 1
crosssectional 1
multicenter 1
study 2
phase 1
ii 1
tlr 1
agonist 1
iss 1
rituximab 1
relapsed 1
refractory 1
follicular 2
lymphoma 2
targeting 1
microenvironment 1
through 1
blockade 1
tnfalpha 1
etanercept 1
